insights_auto
Why is ALCLS down 5.08%?
Dive Deeperchevron_right
ALCLS:EPA
Cellectis SA
€1.05
arrow_downward
-5.08%(-0.056) 1D
Oct 30, 3:34:10 PM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCLS...
Open
€1.14
High
€1.14
Low
€1.03
Mkt. cap
75.37M
Avg. vol.
394.58K
Volume
265.22K
52-wk high
€4.75
52-wk low
€0.90
EPS
-€0.58
Shares outstanding
72.09M
No. of employees
227
Open
€1.14
High
€1.14
Low
€1.03
Mkt. cap
75.37M
Avg. vol.
394.58K
Volume
265.22K
52-wk high
€4.75
52-wk low
€0.90
EPS
-€0.58
Shares outstanding
72.09M
No. of employees
227
News stories
From web sources and news partners
Idéal Investisseur
·
2 days ago
Cellectis share price rises above €0.94 and rebounds by nearly 16%
Profile
Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina. Wikipedia
About Cellectis SA